| 14 Aug, 12:05 pm | — | … | Bliss GVS Pharma Limited has informed the Exchange about Copy of Newspaper Publication regarding the extract of the statement of un-audited standalone andconsolidated financial results for the quarter ended June 30, 2026. | nse |
| 12 Aug, 07:59 pm | — | … | Bliss GVS Pharma Limited has informed the Exchange about General Updates regarding grant of options under Bliss GVS Pharma Limited - Employee Stock Options Plan 2019. | nse |
| 12 Aug, 07:54 pm | — | … | Bliss GVS Pharma Ltd - 506197 - Outcome Of Board Meeting Held On Wednesday, August 12, 2026 | bse |
| 12 Aug, 07:39 pm | — | … | Bliss GVS Pharma Ltd - 506197 - Board Meeting Outcome for Outcome Of Board Meeting Held On Wednesday, August 12, 2026 | bse |
| 12 Aug, 07:38 pm | — | … | Bliss GVS Pharma Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026 along with the Limited Review Report and the draft of the Postal Ballot Notice seeking the approval of members of the Company for the appointment of Mr. Santosh Parab (DIN: 01622988) as a Director of the Company in the capacity of Non-Executive Non-Independent Director of the Company. | nse |
| 11 Aug, 05:57 pm | — | … | Bliss GVS Pharma Limited has informed the Exchange regarding allotment of 31250 securities pursuant to ESOP/ESPS at its meeting held on August 11, 2026 | nse |
| 11 Aug, 01:24 pm | — | … | Bliss GVS Pharma Ltd - 506197 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 | bse |
| 05 Aug, 05:07 pm | — | … | Bliss GVS Pharma Ltd - 506197 - Board Meeting Intimation for Intimation Of Board Meeting To Be Held On Wednesday, August 12, 2026 | bse |
| 27 Jul, 04:44 pm | — | … | SBI Capital Markets Ltd has submitted to the Exchange a copy of pre-offer advertisement in accordance with Regulation 18(7) of the SEBI (SAST) Regulations, 2011, as amended, and corrigendum to the detailed public statement for the attention of the public shareholders of the company. | nse |
| 24 Jul, 07:52 pm | — | … | Bliss GVS Pharma Limited has informed the Exchange about Resignation of Director/KMP/SMP | nse |
| 24 Jul, 07:51 pm | — | … | Bliss GVS Pharma Limited has informed the Exchange regarding Cessation of Mr. Sachin Saboo as Other of the company w.e.f. July 24, 2026. | nse |
| 24 Jul, 07:48 pm | — | … | Bliss GVS Pharma Ltd - 506197 - Announcement under Regulation 30 (LODR)-Cessation | bse |
| 23 Jul, 01:02 pm | — | … | Bliss GVS Pharma Limited has informed the Exchange regarding '' Notice to Shareholders w.r.t. transfer of unclaimed Final Dividend 2018-2019 and its Corresponding Shares to Investor Education and Protection Fund (IEPF) Authority". | nse |
| 22 Jul, 07:13 pm | — | … | Bliss GVS Pharma Limited has informed the Exchange regarding 'the intimation of recommendations by the Committee of Independent Directors pursuant to Regulation 26(7) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 on Open Offer made by the Anupam Rasayan India Limited together with PAC to the Public Shareholders of the Bliss GVS Pharma Limited.' | nse |
| 22 Jul, 05:13 pm | — | … | Bliss GVS Pharma Ltd - 506197 - Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011 | bse |
| 21 Jul, 07:55 pm | — | … | Bliss GVS Pharma Limited has informed the Exchange regarding 'Letter of Offer dated July 18, 2026 received from SBI Capital Markets Limited, the manager to the Open Offer appointed by Anupam Rasayan India Limited along with PAC'. | nse |
| 21 Jul, 07:22 pm | — | … | SBI Capital Markets Ltd has Submitted to the Exchange a copy of letter of offer. | nse |
| 20 Jul, 12:54 pm | — | … | SBI Capital Markets Limited has informed to the Exchange about Addendum to Public Announcement and Detailed Public Statement for the Open Offer made by Anupam Rasayan Limited, the acquirer for the addition of PAC | nse |
| 19 Jul, 08:47 pm | — | … | Bliss GVS Pharma Limited has informed the Exchange about Addendum to Public Announcement and Detailed Public Statement for the Open Offer made by Anupam Rasayan Limited, the acquirer for the addition of PAC. | nse |
| 15 Jul, 01:58 pm | — | … | Bliss GVS Pharma Limited has informed the Exchange regarding 'Contact details of KMPs for reporting of Material Events to Stock Exchanges'. | nse |
| 09 Jul, 06:36 pm | — | … | Bliss GVS Pharma Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. | nse |
| 07 Jul, 06:05 pm | — | … | Bliss GVS Pharma Limited has informed the Exchange regarding allotment of 187750 securities pursuant to ESOP/ESPS at its meeting held on July 07, 2026 | nse |
| 03 Jul, 07:28 pm | — | … | Bliss GVS Pharma Limited has informed the Exchange about Resignation of Director/KMP/SMP | nse |
| 03 Jul, 07:07 pm | — | … | Bliss GVS Pharma Ltd - 506197 - Announcement under Regulation 30 (LODR)-Change in Management | bse |
| 03 Jul, 07:03 pm | — | … | Bliss GVS Pharma Limited has informed the Exchange regarding Appointment of Mr Rahul Adakmol as Chief Executive Officer of the company w.e.f. July 15, 2026. | nse |
| 03 Jul, 07:03 pm | — | … | Bliss GVS Pharma Limited has informed the Exchange regarding Resignation of Mr Narsimha Shibroor Kamath as Chief Executive Officer of the company w.e.f. July 14, 2026. | nse |
| 03 Jul, 07:03 pm | — | … | Bliss GVS Pharma Limited has informed the Exchange regarding Appointment of Mr Santosh Parab as Non- Executive Director of the company w.e.f. July 03, 2026. | nse |
| 03 Jul, 06:59 pm | — | … | Bliss GVS Pharma Limited has informed the Exchange regarding Outcome of Board Meeting held on July 03, 2026. | nse |
| 24 Jun, 03:04 pm | — | … | Bliss GVS Pharma Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. | nse |
| 23 Jun, 06:47 pm | — | … | Bliss GVS Pharma Limited has informed the Exchange regarding 'Please find enclosed herewith the intimation for the Book Closure for the purpose of 41st Annual General Meeting of the Company.'. | nse |
| 23 Jun, 06:46 pm | — | … | Bliss GVS Pharma Limited has informed the Exchange that Record date for the purpose of DI is 08-Jul-2026. | nse |
| 23 Jun, 06:30 pm | — | … | Bliss GVS Pharma Ltd - 506197 - Intimation Of Record Date In Accordance With Regulation 42 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 (''Listing Regulations'') | bse |
| 23 Jun, 06:27 pm | — | … | Bliss GVS Pharma Ltd - 506197 - Intimation Of Book Closure In Accordance With Regulation 42 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 (''Listing Regulations'') | bse |
| 23 Jun, 06:14 pm | — | … | Bliss GVS Pharma Ltd - 506197 - Reg. 34 (1) Annual Report. | bse |
| 19 Jun, 07:42 pm | — | … | Bliss GVS Pharma Limited has informed the Exchange regarding 'the communication sent to shareholders regarding Intimation of Tax Deduction on Dividend.'. | nse |
| 11 Jun, 05:24 pm | procedural | 1 | Bliss GVS Pharma Limited allotted 267,250 ESOP/ESPS securities on Jun 11, 2026. | nse |
| 09 Jun, 07:48 pm | m_and_a | 4 | Bliss GVS Pharma Limited submitted the draft letter of offer for an open offer to public shareholders under SEBI SAST Regulations, 2011. | nse |
| 09 Jun, 10:19 am | m_and_a | 3 | Draft Letter of Offer filed with BSE for an open offer by Anupam Rasayan India Limited to acquire up to 2,77,26,848 Bliss GVS Pharma equity shares (26% of expanded voting share capital) at ₹299/share. | bse |
| 02 Jun, 07:38 pm | — | … | Bliss GVS Pharma Limited has informed the Exchange about Intimation of WHO-GMP Compliance of Manufacturing Facility located at Survey No. 43 & 44, Vevoor Village, Palghar (East). | nse |
| 02 Jun, 02:54 pm | — | … | Bliss GVS Pharma Ltd - 506197 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 | bse |
| 02 Jun, 11:02 am | — | … | SBI Capital Markets Limited (Manager to the Open Offer) has submitted to the Exchange a copy of Detailed Public Statement in terms of Regulation 3(1) and Regulation 4 read with Regulation 13(4), Regulation 15(2) and other applicable Regulations of The Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, as amended, to the Public Shareholders of Bliss GVS Pharma Limited (Target Company). | nse |
| 01 Jun, 07:50 pm | — | … | Bliss GVS Pharma Ltd - 506197 - Detailed Public Statement | bse |
| 01 Jun, 06:54 pm | — | … | Bliss GVS Pharma Ltd - 506197 - Detailed Public Statement In Relation To Open Offer Made To The Public Shareholders Of The Company | bse |
| 28 May, 04:48 pm | — | … | Bliss GVS Pharma Limited has informed the Exchange regarding 'Annual Secretarial Compliance Report for the year ended March 31, 2026'. | nse |
| 28 May, 04:31 pm | — | … | Bliss GVS Pharma Ltd - 506197 - Compliances-Reg.24(A)-Annual Secretarial Compliance | bse |
| 25 May, 07:03 pm | — | … | Bliss GVS Pharma Ltd - 506197 - Announcement under Regulation 30 (LODR)-Change in Management | bse |
| 25 May, 06:57 pm | — | … | Bliss GVS Pharma Limited has informed the Exchange about Mr. Santosh Parab (DIN: 01622988) has completed his second and final term as an Independent Director. Consequently, he ceased to be a Director of the Company with effect from the close of business hours on May 25, 2026, and shall also cease to be a member of the Committees with effect from the same date. | nse |
| 25 May, 11:58 am | — | … | SBI Capital Markets Limited (Manager to the Offer) has submitted to the Exchange a copy of Public Announcement for the attention of the Public Shareholders of Bliss GVS Pharma Limited under Regulation 3(1) and Regulation 4 read with Regulation 13(1), Regulation 14 and Regulation 15(1) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 and subsequent amendments thereto. | nse |
| 23 May, 11:11 pm | — | … | Bliss GVS Pharma Limited has informed the Exchange about Agreements | nse |
| 23 May, 11:06 pm | — | … | Bliss GVS Pharma Ltd - 506197 - Disclosure under Regulation 30A of LODR | bse |